Literature DB >> 7984431

Defining a novel ribonucleotide reductase r1 mRNA cis element that binds to an unique cytoplasmic trans-acting protein.

F Y Chen1, F M Amara, J A Wright.   

Abstract

Ribonucleotide reductase is a highly regulated rate-limiting enzyme activity in DNA synthesis, responsible for reducing ribonucleotides to their deoxyribonucleotide forms. Using 3'-end labeled RNA and band-shift and UV cross-linking analyses, we have identified a cis-element, 5'-CAAACUUC-3', within the 3'-untranslated region of the mammalian ribonucleotide reductase R1 mRNA, which binds a cytoplasmic protein in BALB/c 3T3 mouse cells, to form a 57 kDa RNA-protein complex. Sequence-specific binding was observed, and binding was prevented by several different mutations within the cis-element. We suggest that this cis-trans interaction plays a role in R1 mRNA stability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7984431      PMCID: PMC308532          DOI: 10.1093/nar/22.22.4796

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

Review 1.  Regulated mRNA stability.

Authors:  J A Atwater; R Wisdom; I M Verma
Journal:  Annu Rev Genet       Date:  1990       Impact factor: 16.830

Review 2.  Regulation of mRNA stability and its relevance to disease.

Authors:  B Z Carter; J S Malter
Journal:  Lab Invest       Date:  1991-12       Impact factor: 5.662

3.  A 32-kilodalton protein binds to AU-rich domains in the 3' untranslated regions of rapidly degraded mRNAs.

Authors:  E Vakalopoulou; J Schaack; T Shenk
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 4.  Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis.

Authors:  J A Wright; A K Chan; B K Choy; R A Hurta; G A McClarty; A Y Tagger
Journal:  Biochem Cell Biol       Date:  1990-12       Impact factor: 3.626

5.  Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase.

Authors:  L Thelander; P Berg
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

6.  Reactions at the termini of tRNA with T4 RNA ligase.

Authors:  A G Bruce; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1978-10       Impact factor: 16.971

7.  Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein.

Authors:  I J Rondon; L A MacMillan; B S Beckman; M A Goldberg; T Schneider; H F Bunn; J S Malter
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

8.  Two genetic loci participate in the regulation by iron of the gene for the human transferrin receptor.

Authors:  J L Casey; B Di Jeso; K Rao; R D Klausner; J B Harford
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3'-untranslated region cis-trans interaction through a protein kinase C-controlled pathway.

Authors:  F Y Chen; F M Amara; J A Wright
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

10.  Early induction of ribonucleotide reductase gene expression by transforming growth factor beta 1 in malignant H-ras transformed cell lines.

Authors:  R A Hurta; S K Samuel; A H Greenberg; J A Wright
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

View more
  3 in total

1.  Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins.

Authors:  L A Balmer; D J Beveridge; J A Jazayeri; A M Thomson; C E Walker; P J Leedman
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 2.  mRNA stability in mammalian cells.

Authors:  J Ross
Journal:  Microbiol Rev       Date:  1995-09

3.  Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis.

Authors:  Jana S Eaton; Z Ping Lin; Alan C Sartorelli; Nicholas D Bonawitz; Gerald S Shadel
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.